Announced Fri, 24 Jul · 14:12 IST
Solara Active Pharma Q1 FY27 Results: Revenue up 19.6%, Profit up 55% YoY
Compliance View source PDF
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹522.60
prior close
₹494.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.1-0.0-0.6-3.9—————————
Up moveDown movePending
AI summary
Solara Active Pharma reported Q1 FY27 results. Revenue rose 19.6% YoY to Rs. 381.60 crores; net profit jumped 55% to Rs. 16.31 crores from Rs. 10.52 crores. EPS at Rs. 3.52 vs Rs. 2.46. Yet accumulated losses stand at Rs. 286.21 crores, and results are on a going concern basis. Rights issue collected Rs. 442.73 crores so far. CRAMS and Polymers demerger into a listed entity remains in progress.
Likely market impact
Strong quarter with revenue and profit growth, but watch accumulated losses of Rs. 286 crores and going concern reliance on working capital renewal.